Selected research
Market Structure
Global Ringworm Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Ringworm Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Ringworm Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ringworm Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ringworm Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Ringworm Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ringworm Treatment Drugs include Teva Pharmaceuticals, Inc., Novartis AG, Merck & Co., In, GlaxoSmithKline Plc, Taro Ppharmaceutical Industries Ltd., Perrigo Company plc, Glenmark Pharmaceuticals Inc., Chempro Group India and Avik Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Ringworm Treatment Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ringworm Treatment Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ringworm Treatment Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ringworm Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Ringworm Treatment Drugs Segment by Company
Teva Pharmaceuticals, Inc.
Novartis AG
Merck & Co., In
GlaxoSmithKline Plc
Taro Ppharmaceutical Industries Ltd.
Perrigo Company plc
Glenmark Pharmaceuticals Inc.
Chempro Group India
Avik Pharma
Actiza Pharmaceutical
Ringworm Treatment Drugs Segment by Type
Anti-infective
Antifungals
Steroids
Others
Ringworm Treatment Drugs Segment by Application
Hospital Pharmacies
Drug Stores
E-commerce
Other
Ringworm Treatment Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ringworm Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ringworm Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ringworm Treatment Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ringworm Treatment Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ringworm Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ringworm Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ringworm Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-infective
- Antifungals
- Steroids
- Others
Applications
- Hospital Pharmacies
- Drug Stores
- E-commerce
- Other
Companies covered
- Teva Pharmaceuticals, Inc.
- Novartis AG
- Merck & Co., In
- GlaxoSmithKline Plc
- Taro Ppharmaceutical Industries Ltd.
- Perrigo Company plc
- Glenmark Pharmaceuticals Inc.
- Chempro Group India
- Avik Pharma
- Actiza Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ringworm Treatment Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ringworm Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Ringworm Treatment Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Ringworm Treatment Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Ringworm Treatment Drugs Market Dynamics
- 2.1 Ringworm Treatment Drugs Industry Trends
- 2.2 Ringworm Treatment Drugs Industry Drivers
- 2.3 Ringworm Treatment Drugs Industry Opportunities and Challenges
- 2.4 Ringworm Treatment Drugs Industry Restraints
3 Ringworm Treatment Drugs Market by Manufacturers
- 3.1 Global Ringworm Treatment Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Ringworm Treatment Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Ringworm Treatment Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Ringworm Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ringworm Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ringworm Treatment Drugs Manufacturers, Product Type & Application
- 3.7 Global Ringworm Treatment Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ringworm Treatment Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ringworm Treatment Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Ringworm Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Ringworm Treatment Drugs Market by Type
- 4.1 Ringworm Treatment Drugs Type Introduction
- 4.1.1 Anti-infective
- 4.1.2 Antifungals
- 4.1.3 Steroids
- 4.1.4 Others
- 4.2 Global Ringworm Treatment Drugs Sales by Type
- 4.2.1 Global Ringworm Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ringworm Treatment Drugs Sales by Type (2021-2032)
- 4.2.3 Global Ringworm Treatment Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Ringworm Treatment Drugs Revenue by Type
- 4.3.1 Global Ringworm Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ringworm Treatment Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Ringworm Treatment Drugs Revenue Market Share by Type (2021-2032)
5 Ringworm Treatment Drugs Market by Application
- 5.1 Ringworm Treatment Drugs Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Drug Stores
- 5.1.3 E-commerce
- 5.1.4 Other
- 5.2 Global Ringworm Treatment Drugs Sales by Application
- 5.2.1 Global Ringworm Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ringworm Treatment Drugs Sales by Application (2021-2032)
- 5.2.3 Global Ringworm Treatment Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Ringworm Treatment Drugs Revenue by Application
- 5.3.1 Global Ringworm Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ringworm Treatment Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Ringworm Treatment Drugs Revenue Market Share by Application (2021-2032)
6 Global Ringworm Treatment Drugs Sales by Region
- 6.1 Global Ringworm Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ringworm Treatment Drugs Sales by Region (2021-2032)
- 6.2.1 Global Ringworm Treatment Drugs Sales by Region (2021-2026)
- 6.2.2 Global Ringworm Treatment Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ringworm Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ringworm Treatment Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ringworm Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ringworm Treatment Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ringworm Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ringworm Treatment Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Ringworm Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Ringworm Treatment Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Ringworm Treatment Drugs Revenue by Region
- 7.1 Global Ringworm Treatment Drugs Revenue by Region
- 7.1.1 Global Ringworm Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Ringworm Treatment Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Ringworm Treatment Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Ringworm Treatment Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Ringworm Treatment Drugs Revenue (2021-2032)
- 7.2.2 North America Ringworm Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Ringworm Treatment Drugs Revenue (2021-2032)
- 7.3.2 Europe Ringworm Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Ringworm Treatment Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Ringworm Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Ringworm Treatment Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Ringworm Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva Pharmaceuticals, Inc.
- 8.1.1 Teva Pharmaceuticals, Inc. Company Information
- 8.1.2 Teva Pharmaceuticals, Inc. Business Overview
- 8.1.3 Teva Pharmaceuticals, Inc. Ringworm Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Pharmaceuticals, Inc. Ringworm Treatment Drugs Product Portfolio
- 8.1.5 Teva Pharmaceuticals, Inc. Recent Developments
- 8.2 Novartis AG
- 8.2.1 Novartis AG Company Information
- 8.2.2 Novartis AG Business Overview
- 8.2.3 Novartis AG Ringworm Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Novartis AG Ringworm Treatment Drugs Product Portfolio
- 8.2.5 Novartis AG Recent Developments
- 8.3 Merck & Co., In
- 8.3.1 Merck & Co., In Company Information
- 8.3.2 Merck & Co., In Business Overview
- 8.3.3 Merck & Co., In Ringworm Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck & Co., In Ringworm Treatment Drugs Product Portfolio
- 8.3.5 Merck & Co., In Recent Developments
- 8.4 GlaxoSmithKline Plc
- 8.4.1 GlaxoSmithKline Plc Company Information
- 8.4.2 GlaxoSmithKline Plc Business Overview
- 8.4.3 GlaxoSmithKline Plc Ringworm Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 GlaxoSmithKline Plc Ringworm Treatment Drugs Product Portfolio
- 8.4.5 GlaxoSmithKline Plc Recent Developments
- 8.5 Taro Ppharmaceutical Industries Ltd.
- 8.5.1 Taro Ppharmaceutical Industries Ltd. Company Information
- 8.5.2 Taro Ppharmaceutical Industries Ltd. Business Overview
- 8.5.3 Taro Ppharmaceutical Industries Ltd. Ringworm Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Taro Ppharmaceutical Industries Ltd. Ringworm Treatment Drugs Product Portfolio
- 8.5.5 Taro Ppharmaceutical Industries Ltd. Recent Developments
- 8.6 Perrigo Company plc
- 8.6.1 Perrigo Company plc Company Information
- 8.6.2 Perrigo Company plc Business Overview
- 8.6.3 Perrigo Company plc Ringworm Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Perrigo Company plc Ringworm Treatment Drugs Product Portfolio
- 8.6.5 Perrigo Company plc Recent Developments
- 8.7 Glenmark Pharmaceuticals Inc.
- 8.7.1 Glenmark Pharmaceuticals Inc. Company Information
- 8.7.2 Glenmark Pharmaceuticals Inc. Business Overview
- 8.7.3 Glenmark Pharmaceuticals Inc. Ringworm Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Glenmark Pharmaceuticals Inc. Ringworm Treatment Drugs Product Portfolio
- 8.7.5 Glenmark Pharmaceuticals Inc. Recent Developments
- 8.8 Chempro Group India
- 8.8.1 Chempro Group India Company Information
- 8.8.2 Chempro Group India Business Overview
- 8.8.3 Chempro Group India Ringworm Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Chempro Group India Ringworm Treatment Drugs Product Portfolio
- 8.8.5 Chempro Group India Recent Developments
- 8.9 Avik Pharma
- 8.9.1 Avik Pharma Company Information
- 8.9.2 Avik Pharma Business Overview
- 8.9.3 Avik Pharma Ringworm Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Avik Pharma Ringworm Treatment Drugs Product Portfolio
- 8.9.5 Avik Pharma Recent Developments
- 8.10 Actiza Pharmaceutical
- 8.10.1 Actiza Pharmaceutical Company Information
- 8.10.2 Actiza Pharmaceutical Business Overview
- 8.10.3 Actiza Pharmaceutical Ringworm Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Actiza Pharmaceutical Ringworm Treatment Drugs Product Portfolio
- 8.10.5 Actiza Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ringworm Treatment Drugs Value Chain Analysis
- 9.1.1 Ringworm Treatment Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ringworm Treatment Drugs Production Mode & Process
- 9.2 Ringworm Treatment Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ringworm Treatment Drugs Distributors
- 9.2.3 Ringworm Treatment Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst